All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-31922120
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 31922120 A98G
RT
gag-pol
HIV Infections
D
G
C
L
View
2 31922120 D67G
RT
gag-pol
HIV Infections
D
G
C
L
View
3 31922120 D67N
RT
gag-pol
HIV Infections
D
G
C
L
View
4 31922120 E138G
RT
gag-pol
HIV Infections
D
G
C
L
View
5 31922120 E138Q
RT
gag-pol
HIV Infections
D
G
C
L
View
6 31922120 E44D
RT
gag-pol
HIV Infections
D
G
C
L
View
7 31922120 F227L
RT
gag-pol
HIV Infections
D
G
C
L
View
8 31922120 G190A
RT
gag-pol
HIV Infections
D
G
C
L
View
9 31922120 G190S
RT
gag-pol
HIV Infections
D
G
C
L
View
10 31922120 I84V
PR
gag-pol
HIV Infections
D
G
C
L
View
11 31922120 K101E
RT
gag-pol
HIV Infections
D
G
C
L
View
12 31922120 K101H
RT
gag-pol
HIV Infections
D
G
C
L
View
13 31922120 K101P
RT
gag-pol
HIV Infections
D
G
C
L
View
14 31922120 K103N
RT
gag-pol
HIV Infections
D
G
C
L
View
15 31922120 K103S
RT
gag-pol
HIV Infections
D
G
C
L
View
16 31922120 K219E
RT
gag-pol
HIV Infections
D
G
C
L
View
17 31922120 K219Q
RT
gag-pol
HIV Infections
D
G
C
L
View
18 31922120 K219R
RT
gag-pol
HIV Infections
D
G
C
L
View
19 31922120 K238T
RT
gag-pol
HIV Infections
D
G
C
L
View
20 31922120 K65R
RT
gag-pol
HIV Infections
D
G
C
L
View
21 31922120 K70E
RT
gag-pol
HIV Infections
D
G
C
L
View
22 31922120 K70G
RT
gag-pol
HIV Infections
D
G
C
L
View
23 31922120 K70N
RT
gag-pol
HIV Infections
D
G
C
L
View
24 31922120 K70R
RT
gag-pol
HIV Infections
D
G
C
L
View
25 31922120 L100I
RT
gag-pol
HIV Infections
D
G
C
L
View
26 31922120 L210W
RT
gag-pol
HIV Infections
D
G
C
L
View
27 31922120 L74I
RT
gag-pol
HIV Infections
D
G
C
L
View
28 31922120 L74V
RT
gag-pol
HIV Infections
D
G
C
L
View
29 31922120 L76V
PR
gag-pol
HIV Infections
D
G
C
L
View
30 31922120 M184I
RT
gag-pol
HIV Infections
D
G
C
L
View
31 31922120 M184V
RT
gag-pol
HIV Infections
D
G
C
L
View
32 31922120 M230L
RT
gag-pol
HIV Infections
D
G
C
L
View
33 31922120 M41L
RT
gag-pol
HIV Infections
D
G
C
L
View
34 31922120 M46I
PR
gag-pol
HIV Infections
D
G
C
L
View
35 31922120 P225H
RT
gag-pol
HIV Infections
D
G
C
L
View
36 31922120 T215D
RT
gag-pol
HIV Infections
D
G
C
L
View
37 31922120 T215F
RT
gag-pol
HIV Infections
D
G
C
L
View
38 31922120 T215I
RT
gag-pol
HIV Infections
D
G
C
L
View
39 31922120 T215V
RT
gag-pol
HIV Infections
D
G
C
L
View
40 31922120 T215Y
RT
gag-pol
HIV Infections
D
G
C
L
View
41 31922120 T69G
RT
gag-pol
HIV Infections
D
G
C
L
View
42 31922120 V108I
RT
gag-pol
HIV Infections
D
G
C
L
View
43 31922120 V82A
PR
gag-pol
HIV Infections
D
G
C
L
View
44 31922120 Y115F
RT
gag-pol
HIV Infections
D
G
C
L
View
45 31922120 Y181C
RT
gag-pol
HIV Infections
D
G
C
L
View
46 31922120 Y188L
RT
gag-pol
HIV Infections
D
G
C
L
View
47 31922120 Y318F
RT
gag-pol
HIV Infections
D
G
C
L
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.